Clinical trials

  • NUCRESIRAN for Transthyretin amyloidosis with cardiomyopathy (ATTR amyloidosis with cardiomyopathy)
  • RIMEGEPANT for Migraine|Episodic migraine
  • DURVALUMAB for Triple-negative breast cancer (metastatic, PD-L1-negative)
  • TEBENTAFUSP for Metastatic uveal melanoma | Metastatic uveal melanoma (HLA-A*02:01 positive)
  • CEMIPLIMAB for Non-small cell lung cancer (resected)|Stage II–IIIA non-small cell lung cancer|PD-L1-positive non-small cell lung cancer
  • Dexamethasone sodium phosphate for Acute hypoxemic respiratory failure | Acute respiratory distress syndrome (ARDS)
  • FLUVOXAMINE MALEATE for Depressive disorder
  • Mepolizumab for Chronic rhinosinusitis with nasal polyps
  • Clinical trial in Atopic dermatitis
  • acetylcysteine, glycine, l-lysine acetate, l-tryptophan, glycyl-tyrosine, l-arginine, l-histidine, l-isoleucine, l-leucine, l-methionine, l-proline, l-serine, l-threonine, l-tyrosine, l-valine, l-phenylalanine, l-alanine for Living donor renal transplantation | Renal transplant
  • EVORPACEPT for Breast cancer | Metastatic breast cancer | HER2-positive breast cancer
  • DII235 for Elevated lipoprotein(a) (Lp(a)) | Atherosclerotic cardiovascular disease | Type 2 diabetes mellitus